Academic Journals Database
Disseminating quality controlled scientific knowledge

DMARD’S AND BIOLOGICAL AGENTS: THE SECOND LINE TREATMENT FOR RHEUMATOID ARTHRITIS

ADD TO MY LIST
 
Author(s): Rakesh D.Amrutkar

Journal: International Journal of Pharmaceutical Research and Development
ISSN 0974-9446

Volume: 2;
Issue: 10;
Start page: 18;
Date: 2010;
Original page

Keywords: DMARDs | Biological agents | NSAIDs | Rheumatoid Arthritis (RA)

ABSTRACT
Today, many doctors have changed their approach, especially for patients with severe, rapidly progressing rheumatoid arthritis. Studies show that early treatment with more powerful drugs, and the use of drug combinations instead of one medication alone, may be more effective in reducing or preventing joint damage. Once the disease improves or is in remission, the doctor may gradually reduce the dosage or prescribe a milder medication. Some medications are used only for pain relief; others are used to reduce inflammation. Still others, often called Disease-Modifying Antirheumatic drugs (DMARDs), are used to try to slow the course of the disease. Biologic response modifiers are new drugs used for the treatment of rheumatoid arthritis. Current article highlights the important aspect of Rheumatoid arthritis, special emphasis on its therapy majorally DMARDs, Biological agents and the growing use of DMARDs, Biological agents v/s Analgesics and Nonsteroidal Anti-inflammatory Drugs (NSAIDs).
Why do you need a reservation system?      Affiliate Program